NDC 46708-493 – Tizanidine Hydrochloride
Tizanidine Hydrochloride 6 mg/1 · Capsule · Oral
Product NDC46708-493
Product details
- Brand name
- Tizanidine Hydrochloride
- Generic name
- Tizanidine Hydrochloride
- Labeler
- Alembic Pharmaceuticals Limited
- Dosage form
- Capsule
- Route
- Oral
- Marketing category
- ANDA · ANDA213223
- Marketed since
- January 15, 2020
- Listing expires
- December 31, 2026
- Pharmacologic class
- Central alpha-2 Adrenergic Agonist
Active ingredients
- Tizanidine Hydrochloride 6 mg/1
Uses, dosage, side effects and warnings for tizanidine hydrochloride →
Package NDC codes (4)
| Package NDC | Description | Since |
|---|---|---|
| 46708-493-08 | 80 BLISTER PACK in 1 CARTON (46708-493-08) / 8 CAPSULE in 1 BLISTER PACK | Jan 15, 2020 |
| 46708-493-30 | 30 CAPSULE in 1 BOTTLE (46708-493-30) | Jan 15, 2020 |
| 46708-493-41 | 150 CAPSULE in 1 BOTTLE (46708-493-41) | Jan 15, 2020 |
| 46708-493-91 | 1000 CAPSULE in 1 BOTTLE (46708-493-91) | Jan 15, 2020 |
Other tizanidine hydrochloride products
- 0591-2788 Tizanidine Hydrochloride 2 mg/1 · Capsule, Gelatin Coated · Actavis Pharma, Inc.
- 0591-2789 Tizanidine Hydrochloride 4 mg/1 · Capsule, Gelatin Coated · Actavis Pharma, Inc.
- 0591-2790 Tizanidine Hydrochloride 6 mg/1 · Capsule, Gelatin Coated · Actavis Pharma, Inc.
- 72888-003 Tizanidine Hydrochloride 6 mg/1 · Capsule · Advagen Pharma Limited
- 72888-161 Tizanidine Hydrochloride 8 mg/1 · Capsule · Advagen Pharma Limited
- 72888-002 Tizanidine Hydrochloride 4 mg/1 · Capsule · Advagen Pharma Limited
- 72888-001 Tizanidine Hydrochloride 2 mg/1 · Capsule · Advagen Pharma Limited
- 80425-0474 Tizanidine Hydrochloride 4 mg/1 · Capsule · Advanced Rx of Tennessee, LLC
- 80425-0448 Tizanidine Hydrochloride 6 mg/1 · Capsule · Advanced Rx of Tennessee, LLC
- 62332-492 Tizanidine Hydrochloride 4 mg/1 · Capsule · Alembic Pharmaceuticals Inc.
- 62332-491 Tizanidine Hydrochloride 2 mg/1 · Capsule · Alembic Pharmaceuticals Inc.
- 62332-493 Tizanidine Hydrochloride 6 mg/1 · Capsule · Alembic Pharmaceuticals Inc.